Literature DB >> 10880699

Opiate withdrawal in the fetal rat: a behavioral profile.

K L Jones1, G A Barr.   

Abstract

Offspring of women exposed to opiate drugs such as heroin and methadone during pregnancy have a high incidence of morbidity and mortality. Infants also show opiate withdrawal. In this study, we examined the behavioral effects of precipitated withdrawal in morphine-dependent fetal rats at gestational day (GD) 20. The dam was implanted on GD 14 with a pellet containing 75.0 mg of morphine. On GD 20, the dam underwent chemoyelotomy at L1/L2. The uterine horns were externalized and four subject fetuses were selected for behavioral observation, two from each uterine horn. The fetus was then injected subcutaneously with either saline or naltrexone (1.0 mg/kg) and the behaviors of the fetus recorded every 15 sec for 20 min. The results show that naltrexone injected fetuses that had been chronically exposed to morphine demonstrated increased limb and mouth movements, face wiping, and body curls, and spent less time quiet as compared with control fetuses. These results indicate that a morphine withdrawal-like syndrome occurs in the fetal rat.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10880699     DOI: 10.1016/s0091-3057(00)00209-4

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  6 in total

1.  In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome.

Authors:  Bryce A Griffin; Caitlin O Caperton; Lauren N Russell; Christian V Cabanlong; Catheryn D Wilson; Kyle R Urquhart; Bradford S Martins; Marcelle Dina Zita; Amy L Patton; Alexander W Alund; S Michael Owens; William E Fantegrossi; Jeffery H Moran; Lisa K Brents
Journal:  J Pharmacol Exp Ther       Date:  2019-04-26       Impact factor: 4.030

2.  Central effects of ethanol interact with endogenous mu-opioid activity to control isolation-induced analgesia in maternally separated infant rats.

Authors:  Michael E Nizhnikov; Andrey P Kozlov; Tatiana A Kramskaya; Elena I Varlinskaya; Norman E Spear
Journal:  Behav Brain Res       Date:  2013-12-04       Impact factor: 3.332

Review 3.  Changing mechanisms of opiate tolerance and withdrawal during early development: animal models of the human experience.

Authors:  Gordon A Barr; Anika McPhie-Lalmansingh; Jessica Perez; Michelle Riley
Journal:  ILAR J       Date:  2011

4.  Automated quantification of opioid withdrawal in neonatal rat pups using Ethovision® XT software.

Authors:  Hanna J Kulbeth; Saki Fukuda; Lisa K Brents
Journal:  Neurotoxicol Teratol       Date:  2021-01-30       Impact factor: 3.763

5.  A Novel Strategy for Attenuating Opioid Withdrawal in Neonates.

Authors:  Giovanni C Santoro; Samarth Shukla; Krishna Patel; Jakub Kaczmarzyk; Stergiani Agorastos; Sandra Scherrer; Yoon Young Choi; Christina Veith; Joseph Carrion; Rebecca Silverman; Danielle Mullin; Mohamed Ahmed; Wynne K Schiffer; Jonathan D Brodie; Stephen L Dewey
Journal:  J Addict Res Ther       Date:  2016-08-11

6.  N-acetylcysteine mitigates acute opioid withdrawal behaviors and CNS oxidative stress in neonatal rats.

Authors:  Price Ward; Hunter G Moss; Truman R Brown; Peter Kalivas; Dorothea D Jenkins
Journal:  Pediatr Res       Date:  2020-01-14       Impact factor: 3.756

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.